These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

321 related items for PubMed ID: 2674436

  • 21. Angiotensin-converting enzyme inhibitors in hypertension: a review.
    Salvetti A, Pedrinelli R, Arzilli F, Abdel-Haq B, Magagna A, Lucarini A, Graziadei L, Nuccorini A, Taddei S.
    Int J Clin Pharmacol Res; 1985; 5(6):429-38. PubMed ID: 3005182
    [Abstract] [Full Text] [Related]

  • 22. Progressive renal insufficiency: the role of angiotensin converting enzyme inhibitors.
    Savage S, Schrier RW.
    Adv Intern Med; 1992; 37():85-101. PubMed ID: 1558007
    [Abstract] [Full Text] [Related]

  • 23. Long-term protection of obese Zucker rat kidneys from fibrosis and renal failure with an angiotensin-converting enzyme inhibitor/diuretic combination.
    Renaud IM, Chainey A, Belair MF, Mandet C, Michel O, Myara I, Chevalier J, Plante GE.
    Fundam Clin Pharmacol; 2004 Aug; 18(4):437-47. PubMed ID: 15312150
    [Abstract] [Full Text] [Related]

  • 24. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR.
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [Abstract] [Full Text] [Related]

  • 25. Comparison of the effects of angiotensin-converting enzyme inhibition and angiotensin II receptor blockade on the evolution of spontaneous glomerular injury in male MWF/Ztm rats.
    Remuzzi A, Malanchini B, Battaglia C, Bertani T, Remuzzi G.
    Exp Nephrol; 1996 Sep; 4(1):19-25. PubMed ID: 8788596
    [Abstract] [Full Text] [Related]

  • 26. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
    Vogt L, Kocks MJ, Laverman GD, Navis G.
    Minerva Med; 2004 Oct; 95(5):395-409. PubMed ID: 15467515
    [Abstract] [Full Text] [Related]

  • 27. A randomized and double-blind comparison of isradipine and spirapril as monotherapy and in combination on the decline in renal function in patients with chronic renal failure and hypertension.
    Petersen LJ, Petersen JR, Talleruphuus U, Møller ML, Ladefoged SD, Mehlsen J, Jensen HA.
    Clin Nephrol; 2001 May; 55(5):375-83. PubMed ID: 11393383
    [Abstract] [Full Text] [Related]

  • 28. Angiotensin converting enzyme inhibitors and progression of chronic renal failure.
    Tolins JP, Raij L.
    Kidney Int Suppl; 1990 Nov; 30():S118-22. PubMed ID: 2259070
    [Abstract] [Full Text] [Related]

  • 29. Antihypertensive therapy in renal disease and transplantation.
    Mimran A, Ribstein J.
    J Hypertens Suppl; 1992 Jul; 10(5):S79-85. PubMed ID: 1403237
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Long-term renoprotective effect of combination therapy with prostaglandin E1 and angiotensin-converting enzyme inhibitor in patients with chronic renal failure.
    Nakayama Y, Nonoguchi H, Kiyama S, Kohda Y, Inoue T, Tomita K.
    Hypertens Res; 2005 Sep; 28(9):733-9. PubMed ID: 16419646
    [Abstract] [Full Text] [Related]

  • 32. Consequences of renal morphologic damage induced by inhibition of converting enzyme in rat renovascular hypertension.
    Michel JB, Nochy D, Choudat L, Dussaule JC, Philippe M, Chastang C, Corvol P, Menard J.
    Lab Invest; 1987 Oct; 57(4):402-11. PubMed ID: 2823006
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Renal protection and angiotensin converting enzyme inhibition in microalbuminuric type I and type II diabetic patients.
    Cooper ME.
    J Hypertens Suppl; 1996 Dec; 14(6):S11-4. PubMed ID: 9023709
    [Abstract] [Full Text] [Related]

  • 37. [Renal function during treatment with angiotensin converting enzyme inhibitors].
    Rasmussen K, Heitmann M, Nielsen JI, Møgelvang JC.
    Ugeskr Laeger; 1995 Sep 25; 157(39):5377-81. PubMed ID: 7483049
    [Abstract] [Full Text] [Related]

  • 38. [Are all antihypertensive drugs renoprotective?].
    Wolf S, Risler T.
    Herz; 2004 May 25; 29(3):248-54. PubMed ID: 15167950
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.